These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 21683069
21. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes. Fionda C, Nappi F, Piccoli M, Frati L, Santoni A, Cippitelli M. Mol Pharmacol; 2007 Nov; 72(5):1246-57. PubMed ID: 17673570 [Abstract] [Full Text] [Related]
22. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells. Kondoh K, Tsuji N, Asanuma K, Kobayashi D, Watanabe N. Exp Cell Res; 2007 Oct 01; 313(16):3486-96. PubMed ID: 17706193 [Abstract] [Full Text] [Related]
23. 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state. Katura T, Moriya T, Nakahata N. Mol Pharmacol; 2010 Apr 01; 77(4):601-11. PubMed ID: 20086036 [Abstract] [Full Text] [Related]
24. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions. Ueki S, Kato H, Kobayashi Y, Ito W, Adachi T, Nagase H, Ohta K, Kayaba H, Chihara J. Int Arch Allergy Immunol; 2007 Apr 01; 143 Suppl 1():15-22. PubMed ID: 17541271 [Abstract] [Full Text] [Related]
25. 15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines. Liu X, Yu H, Yang L, Li C, Li L. Eur J Cell Biol; 2012 Aug 01; 91(8):654-61. PubMed ID: 22560326 [Abstract] [Full Text] [Related]
26. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. Napimoga MH, Souza GR, Cunha TM, Ferrari LF, Clemente-Napimoga JT, Parada CA, Verri WA, Cunha FQ, Ferreira SH. J Pharmacol Exp Ther; 2008 Jan 01; 324(1):313-21. PubMed ID: 17928570 [Abstract] [Full Text] [Related]
27. 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces mitochondrial-dependent apoptosis through inhibition of PKA/NF-kappaB in renal proximal epithelial cells. Lee DR, Kwon CH, Park JY, Kim YK, Woo JS. Toxicology; 2009 Apr 05; 258(1):17-24. PubMed ID: 19167456 [Abstract] [Full Text] [Related]
28. Treatment of etoposide combined with 15-deoxy-Δ12,14-prostaglandin J2 exerted synergistic antitumor effects against renal cell carcinoma via peroxisome proliferator-activated receptor-γ-independent pathways. Yamamoto Y, Koma H, Hiramatsu H, Abe M, Murakami K, Ohya A, Yagami T. Mol Clin Oncol; 2014 Mar 05; 2(2):292-296. PubMed ID: 24649349 [Abstract] [Full Text] [Related]
29. The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cells. Jung WK, Lee CM, Lee DS, Na G, Lee DY, Choi I, Park SG, Seo SK, Yang JW, Choi JS, Lee YM, Park WS, Choi IW. Int J Mol Med; 2014 Feb 05; 33(2):449-56. PubMed ID: 24337644 [Abstract] [Full Text] [Related]
30. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. Chen ZY, Tseng CC. Mol Pharmacol; 2005 Nov 05; 68(5):1203-13. PubMed ID: 16077033 [Abstract] [Full Text] [Related]
31. HtrA3 is regulated by 15-deoxy-Delta12,14-prostaglandin J2 independently of PPARgamma in clear cell renal cell carcinomas. Théoleyre S, Mottier S, Masson D, Denis MG. Biochem Biophys Res Commun; 2010 Apr 09; 394(3):453-8. PubMed ID: 19951697 [Abstract] [Full Text] [Related]
32. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells. Chbicheb S, Yao X, Rodeau JL, Salamone S, Boisbrun M, Thiel G, Spohn D, Grillier-Vuissoz I, Chapleur Y, Flament S, Mazerbourg S. Biochem Pharmacol; 2011 May 01; 81(9):1087-97. PubMed ID: 21338579 [Abstract] [Full Text] [Related]
33. High-performance affinity purification for identification of 15-deoxy-Δ 12,14 -PGJ₂ interacting factors using magnetic nanobeads. Maekawa N, Hiramoto M, Sakamoto S, Azuma M, Ito T, Ikeda M, Naitou M, Acharya HP, Kobayashi Y, Suematsu M, Handa H, Imai T. Biomed Chromatogr; 2011 Apr 01; 25(4):466-71. PubMed ID: 21374648 [Abstract] [Full Text] [Related]
34. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions. Suzuki T, Hayashi S, Miki Y, Nakamura Y, Moriya T, Sugawara A, Ishida T, Ohuchi N, Sasano H. Endocr Relat Cancer; 2006 Mar 01; 13(1):233-50. PubMed ID: 16601291 [Abstract] [Full Text] [Related]
35. Development of enzyme-linked immunosorbent assay for Δ12-prostaglandin J2 and its application to the measurement of the endogenous product generated by cultured adipocytes during the maturation phase. Hossain MS, Chowdhury AA, Rahman MS, Nishimura K, Jisaka M, Nagaya T, Shono F, Yokota K. Prostaglandins Other Lipid Mediat; 2011 Apr 01; 94(3-4):73-80. PubMed ID: 21237281 [Abstract] [Full Text] [Related]
36. The prostanoid 15-deoxy-Δ12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection. Cloutier A, Marois I, Cloutier D, Verreault C, Cantin AM, Richter MV. J Infect Dis; 2012 Feb 15; 205(4):621-30. PubMed ID: 22219346 [Abstract] [Full Text] [Related]
37. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Kim EH, Surh YJ. Biochem Pharmacol; 2006 Nov 30; 72(11):1516-28. PubMed ID: 16987499 [Abstract] [Full Text] [Related]
38. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. Kim EJ, Park KS, Chung SY, Sheen YY, Moon DC, Song YS, Kim KS, Song S, Yun YP, Lee MK, Oh KW, Yoon DY, Hong JT. J Pharmacol Exp Ther; 2003 Nov 30; 307(2):505-17. PubMed ID: 12966153 [Abstract] [Full Text] [Related]
39. Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells. Wang JJ, Mak OT. Prostaglandins Other Lipid Mediat; 2011 Apr 30; 94(3-4):104-11. PubMed ID: 21396480 [Abstract] [Full Text] [Related]